<DOC>
	<DOCNO>NCT01927731</DOCNO>
	<brief_summary>The goal clinical research study learn take Promacta ( eltrombopag ) help platelet count improve faster stem cell transplant . The safety drug also study .</brief_summary>
	<brief_title>Eltrombopag Cord Blood Haploidentical Bone Marrow Transplantation</brief_title>
	<detailed_description>Study Drug Administration : If agree take part study , take eltrombopag mouth 1 time day 60 day . The study drug take empty stomach ( 1 hour 2 hour food/drink ) . You may drink water , coffee , and/or tea study drug . Do use milk cream coffee tea . If vomit drug within 30 minute take , dose repeat . If cord blood transplant , start take eltrombopag 1 day transplant ( Day -1 ) . If ( ) haploidentical transplant , start take eltrombopag 5 day transplant ( Day +5 ) . Study Visits : You admit hospital part transplant stay blood draw daily standard transplant care check blood count , kidney liver function . Once discharge , see outpatient 1-3 time per week standard post-transplant care . Blood ( 1 tablespoon ) drawn week take eltrombopag , week 4 week last dose eltrombopag check blood count , kidney , liver function . About 1 , 2 , 3 , 6 , 12 month transplant , blood ( 5 tablespoon ) draw check immune system . If blood and/or platelet transfusion , research staff record number transfusion receive study . Length Study : You study 1 year . You take study early platelet count becomes high , intolerable side effect , unable follow study direction , doctor think best interest , choose leave study early . This investigational study . Eltrombopag FDA approve commercially available treatment low platelet count patient idiopathic thrombocytopenic purpura ( ITP -- severe bleed disease ) . Its use patient low platelet count stem cell transplant investigational . Up 60 patient take part study . All enrol MD Anderson .</detailed_description>
	<criteria>1 . Patients undergo cord blood haploidentical transplantation protocol standard care treatment plan . 2 . Age &gt; /= 18 . 3 . Females child bear potential define postmenopausal 12 month previous surgical sterilization breastfeeding must willing use effective contraceptive measure 30 day last dose eltrombopag . Males sexual contact female childbearing potential must willing use contraceptive technique 30 day last dose eltrombopag . 4 . Patient patient 's legal representative ( ) is/are able provide write informed consent participate . 1 . ALT AST &gt; /= 2.5 ULN . 2 . Serum direct bilirubin &gt; /= 1 mg/dl ( except Gilbert 's syndrome hemolysis ) . 3 . Patients east Asian ancestry ( Chinese , Japanese , Korean Origin ) . 4 . Calculated creatinine clearance &lt; 30ml./min . Creatinine clearance calculate use MDRD method . 5 . Arterial venous thrombosis last year except linerelated venous thrombosis 3 month ago . 6 . Positive beta HCG within 7 day prior consent female childbearing potential define postmenopausal 12 month previous surgical sterilization breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Blood And Marrow Transplantation</keyword>
	<keyword>Cord blood transplantation</keyword>
	<keyword>CBT</keyword>
	<keyword>Platelet count</keyword>
	<keyword>Haploidentical donor stem cell transplant</keyword>
	<keyword>Eltrombopag</keyword>
	<keyword>Promacta</keyword>
</DOC>